Apr 5 |
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
|
Apr 5 |
Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive?
|
Apr 5 |
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
|
Apr 3 |
Carpenter Technology, Natera, ethereum pitched as long ideas at Sohn conference
|
Apr 1 |
Natera and Alliance for Clinical Trials in Oncology announce activation of mid-stage trial in urothelial cancer
|
Apr 1 |
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
|
Mar 22 |
Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
|
Mar 21 |
11 Best Healthcare ETFs To Buy Now
|